Entity family

Browse treatments

Clinical therapies and care approaches used to manage a condition. Examples include immunotherapy, radiotherapy, rehabilitation.

1articles mentioning treatments

1treatment mentions

1distinct treatments extracted

0%of mentions human-reviewed

Active filtersEntity: eTRE-MD ×

eTRE-MD

This treatment is selected. Its supporting articles are shown below.

Articles mentioning eTRE-MD

1 articles · page 1 of 1

Effect of an early time restricted eating Mediterranean diet compared to naltrexone/bupropion on liver fibrosis in people with cardiometabolic risk factors in a hospital outpatient clinic: study protocol for a randomised controlled trial (MEDFAST trial)

bmjopen · abstract · 2026-06-25 · 1 matching annotations

76.3%

eTRE-MD Weight loss hepatocellular carcinoma naltrexone/bupropion liver cirrhosis type 2 diabetes N/B Metabolic dysfunction-associated steatotic liver disease (MASLD)liver fibrosis T2D+3 more

…ed as LSM (>7.0 kPa and <13.6 kPa). The diet group will receive eTRE-MD, with a 10-hour eating time restriction (8AM–6PM). The medicati…